LONDON, June 8, 2018 /PRNewswire/ --
C1 Esterase Inhibitor, Selective Bradykinin B2 ReceptorAntagonist, Kallikrein Inhibitor (Kalbitor), Cinryze, Berinert, Ruconest, Intravenous, Subcutaneous Injection, Oral, Hospital Pharmacies, Retail Pharmacies
The global hereditary angioedema market is expected to grow at a CAGR of 8.8% in the first
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 232-page report you will receive 82 tables and 130 figures- all unavailable elsewhere.
The 232-page report provides clear detailed insight into the global hereditary angioedema market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
• Global Hereditary Angioedema Market Forecast from 2018-2028
• This report also breaks down the revenue forecast for the global hereditary angioedema market by drug class: • C1 Esterase Inhibitor: Cinryze, Berinert, Ruconest • Selective Bradykinin B2 Receptor Antagonist • Kallikrein Inhibitor (Kalbitor)
This report also provides a market attractiveness index by drug class.
• This report also breaks down the revenue forecast for the global hereditary angioedema market by route of administration: • Intravenous • Subcutaneous Injection • Oral
This report also provides a market attractiveness index by route of administration.
• This report also breaks down the revenue forecast for the global hereditary angioedema market by distribution channel: • Hospital Pharmacies • Retail Pharmacies
This report also provides a market attractiveness index by distribution channel
• This report provides individual revenue forecasts to 2028 for these regional and national markets: • North America: The U.S., Canada • Latin America: Brazil, Mexico, Rest of Latin America • Europe: U.K., Germany, Spain, France, Italy, Russia, Rest of Europe • Asia-Pacific: China, India, Japan, Australia and New Zealand, South Korea, ASEAN, Rest of Asia-Pacific • Middle East: GCC Countries, Israel, Rest of Middle East • Africa: South Africa, Central Africa, North Africa
This report also provides a market attractiveness index by region
The forecast for each regional market is further broken down by drug class, product, route of administration and distribution channel
This report provides a market attractiveness index by drug class, product, route of administration and distribution channel for each regional market
• Our study discusses the selected leading companies that are the major players in the global hereditary angioedema industry: • BioCryst Pharmaceuticals, Inc. • CSL Limited • iBio, Inc. • Ionis Pharmaceuticals, Inc. • Pharming Group NV • Santarus, Inc. • Shire PLC
• This report discusses factors that drive and restrain the market, as well as trends and opportunities.
Visiongain's study is intended for anyone requiring commercial analyses for the global hereditary angioedema market. You find data, trends and predictions.
Buy our report today Global Hereditary Angioedema Market Forecast 2018-2028: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor (Kalbitor), Cinryze. Berinert, Ruconest, Intravenous, Subcutaneous Injection, Oral, Hospital Pharmacies, Retail Pharmacies.
To request a report overview of this report please contact Sara Peerun at email@example.com or refer to our website : https://www.visiongain.com/Report/2203/Global-Hereditary-Angioedema-Market-Forecast-2018-2028
AmeriCare BioCryst Pharmaceuticals, Inc Clinigen Group plc CSL Behring CSL Intellectual Property CSL Limited Dyax Corp. Fiocruz HAEi International Patient Organization iBio, Inc. iBio, Inc. Idera Pharmaceuticals Inceptua Medicines Access Ionis Pharmaceuticals, Inc. Pharming Group NV Prime Therapeutics LLC Salix Pharmaceuticals, Inc. Salix Pharmaceuticals, Ltd. Sanquin Blood Supply Santarus, Inc. Seqirus Shire plc United States of America US Hereditary Angioedema Association Valeant Pharmaceuticals International, Inc. ViroPharma Inc. World Allergy Organization
To see a report overview please e-mail Sara Peerun on firstname.lastname@example.org
Subscribe to our Free Newsletters!
Donating blood is a life-saving act. Consider increasing your iron intake before and after you ...
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...View All